Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06233747 · ClinicalTrials.gov registry record · NA
Improving Care, Accelerating Recovery and Education
A NA study of Suicidal Ideation and Mental Health Disorder, sponsored by Dartmouth-Hitchcock Medical Center.
- Active
- Registry status
- NA
- Development phase
- 109
- Enrollment target
- 2
- Study locations
NCT06233747: Active NA study of Suicidal Ideation and Mental Health Disorder, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06233747 is a NA study of Suicidal Ideation and Mental Health Disorder that is active but no longer recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 109 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06233747, a NA study of Suicidal Ideation and Mental Health Disorder, is active but no longer recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment. The main questions it aims to answer are: * Can the I-CARE program be used at the medical hospitals and do the patients and hospital staff like the program? * Does the I-CARE program lower patients' emotional distress, thoughts about suicide or suicide attempts? Patients will complete as many of the 7 I-CARE videos as possible during their stay at the medical hospital and fill out online surveys. There are workbook activities that go with each I-CARE video. A hospital staff member will help the patient do the videos and workbook activities.
Primary Outcome
The DASS-Y is a 21-item, youth-oriented validated measure that generates an aggregate assessment of emotional distress and sub-measures of depression, anxiety, and stress. Each item is self-reported on a 4-point Likert scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much, or most of the time).
Conditions Studied
Interventions
- BEHAVIORAL Improving Care, Accelerating Recovery & Education (ICARE)
Study Locations (2)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2024-02-29 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT06233747 still lists
NCT06233747 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (59% lower).
The record links to 4 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Improving Care, Accelerating Recovery & Education (ICARE) is the first listed.
NCT06233747 reports a single indexed study location in Pennsylvania, Vermont.
Frequently Asked Questions
What is clinical trial NCT06233747 about?
NCT06233747 is a clinical study titled "Improving Care, Accelerating Recovery and Education". The goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment. The main questions it aims to answer are: * Can the I-CARE program be used at the medical hospitals and do the patients and hospital staff like the pro...
What is the current status of trial NCT06233747?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 109 participants. The study started on 2024-02-29. Estimated completion is 2026-07-31.
What conditions does trial NCT06233747 study?
This clinical trial studies the following conditions: Suicidal Ideation, Mental Health Disorder, Suicide Attempt, Emergency Psychiatric.
What interventions are being tested in trial NCT06233747?
The interventions under investigation include: Improving Care, Accelerating Recovery & Education (ICARE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06233747?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06233747 being conducted?
This trial has 2 study locations across Pennsylvania, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06233747's enrollment target sits among peer trials
109 40th of 84 higher than 45 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI